Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

ELIXA Investigators

Research output: Contribution to journalArticle

68 Scopus citations

Fingerprint Dive into the research topics of 'Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo'. Together they form a unique fingerprint.

Medicine & Life Sciences